Mineralys Therapeutics, Inc.

MLYS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001933414

SEC filings (opens in a new tab)

In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Mineralys Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of MLYS: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	68	68	0
Shares	24.6M	25.2M	+572.0K (+2.3%)
Value	$385.4M	$429.2M	+$43.8M (+11.4%)

New holders (10)

Institutions that held Mineralys Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to MLYS in Q2 2023
Institution	Shares	Value	% of portfolio
Bank of Montreal	101,724	$1.51M	0.00%
Alps Advisors Inc	30,031	$512.0K	0.00%
Panagora Asset Management Inc	23,016	$392.4K	0.00%
Federated Hermes, Inc.	20,593	$351.1K	0.00%
Letko, Brosseau & Associates Inc	11,400	$194.4K	0.00%
Alliancebernstein L.P.	11,080	$188.9K	0.00%
UBS Group AG	8,006	$136.5K	0.00%
Virtus ETF Advisers LLC	6,817	$116.2K	0.07%
Citigroup Inc	4,154	$70.8K	0.00%
Versant Capital Management, Inc	32	$546	0.00%

Sold out (10)

Institutions that held Mineralys Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of MLYS in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Logos Global Management LP	300,000	$4.70M
Citadel Advisors LLC	191,048	$2.99M
Opaleye Management Inc.	115,000	$1.80M
Monashee Investment Management LLC	110,000	$1.72M
ArrowMark Colorado Holdings LLC	62,500	$978.8K
Point72 Middle East FZE	36,822	$576.6K
Walleye Capital LLC	25,996	$407.1K
Wellington Management Group LLP	24,224	$379.3K
Cubist Systematic Strategies, LLC	10,227	$160.2K
CWM, LLC	13	$0